Skip to content

Clinical trials

Phase 3 Lung Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 3 Country / region: Taiwan Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20171
20192
20221
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Pfizer2
United Therapeutics2
Eli Lilly and Company1
Mannkind Corporation1
Nuvalent Inc.1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases12
Respiratory Tract Diseases8
Infections4
Respiratory Tract Infections4
COVID-193
Carcinoma, Non-Small-Cell Lung3
Coronavirus Infections3
Lung Diseases, Obstructive3
Lung Neoplasms3
Virus Diseases3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.